COVID-19 RAPID TESTING

Covid Rapid Testing Service

Precede offers Rapid COVID-19 testing services for employees/employers or individuals. The COVID-19 IgG and IgM Rapid Test is used for the qualitative detection of the SARS-CoV-2 antibodies screening, through the use of rapid detection tests (RADTs, or rapid tests), and can potentially identify positive cases earlier (within 15 minutes) to help reduce the spread of the virus and prevent outbreaks. When used regularly, rapid tests may help identify individuals who may be infectious early on. Individuals can be pre-symptomatic or asymptomatic but still carry the virus and may transmit it to others.

Find out more

Important USA travel information

As of June 13, 2022 flights departing to the US from a foreign country at or after that time no longer have to present a negative test result or documentation of recovery in the past 90 days from Covid-19.

What is a Covid-19 Rapid Test?

The COVID-19 Rapid Test is a 15-minute test that detects the presence of the SARS-CoV-2 antibodies in . This is one of 3 types of tests that are used to identify the presence of COVID-19. T

his is the first COVID-19 IgM/IgG Antibody Rapid Test to be licensed by Health Canada (Class III). The device is also approved by the FDA in the US. This on-site rapid test detects antibodies produced when infected by the COVID-19 virus (Coronavirus Disease), caused by 2019-nCoV (SARS-CoV-2).

This test is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in direct anterior nasal swabs from individuals who are either suspected of COVID-19 by their health care provider within the first five days of the onset of symptoms, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.

How Covid-19 rapid tests work

The COVID-19 Rapid Test is a simple point-of-care lateral flow immunoassay detecting IgM and IgG antibodies simultaneously against the COVID-19 virus within 15 minutes detecting patients at different infection stages. It does not detect the COVID-19 virus itself, but the antibodies produced to fight the virus.

It is widely accepted that IgM provides the first line of defense during viral infections, followed by the generation of adaptive, high affinity IgG responses for long-term immunity and immunological memory. Therefore, testing of COVID-19 IgM and IgG antibodies is an effective method for the rapid diagnosis of COVID-19 infection.

Furthermore, detection of COVID-19 IgM antibodies tends to indicate a recent exposure to COVID-19, whereas detection of COVID-19 IgG antibodies indicates a later stage of infection. Thus, this combined antibody test could also provide information on the stage of infection.

Our Covid-19 Rapid Test Features

  • Detects antibodies 5-7 days after symptoms first appear
  • Provides clear results within 15 minutes to our Registered Nurse and/or Occupational Health Tech
  • Offered both in our Precede Clinics, as well as virtually via our Tele-Health platform
  • Affordable
  • FDA Approved in the USA & expected to pass Class 3 Licensing in Canada on March 30
  • Minimally invasive test options (mid nasal swab)
Girls looking at a Covid-19 test

– Back to Services –

OCCUPATIONAL HEALTH

DISABILITY MANAGEMENT

COVID-19

TRAINING AND EDUCATION

Get started with Precede

SCHEDULE A SERVICE START TELEHEALTH

Precede

In the spirit of reconciliation, we acknowledge that our organization is headquartered on the traditional territories of the Blackfoot Confederacy (Siksika, Kainai, Piikani), the Tsuut’ina, the Îyâxe Nakoda Nations, the Métis Nation (Region 3), and all people who make their homes in the Treaty 7 region of Southern Alberta.

Corporate Headquarters

Suite #120 11012 Macleod Trail SE
Calgary, AB

Call Us: +1-866-989-0499

info@precedeohs.com

© 2022 Precede

Privacy policy